Argenx (ARGX)
(Delayed Data from NSDQ)
$368.60 USD
-6.40 (-1.71%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $368.55 -0.05 (-0.01%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ARGX 368.60 -6.40(-1.71%)
Will ARGX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ARGX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ARGX
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
GSK Gears Up for Q1 Earnings: Here's What to Expect
ARGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday
Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last?
Other News for ARGX
Artisan International Fund Q1 2024 Commentary
Baron Health Care Fund Q1 2024 Shareholder Letter
Analysts’ Top Healthcare Picks: Elevance Health (ELV), Argenx Se (ARGX)
Maintaining the Edge: Argenx’s Hold Rating Amidst Rising Competition and Promising Therapy Results
The Analyst Verdict: argenx In The Eyes Of 12 Experts